Population Management: A Tool to Improve Timely Care in Pediatric and Young Adult Patients with Inflammatory Bowel Disease

Table 1

CHAM IBD patient demographics.

Variable	No. (%)
Age
0-5	1 (1%)
6-10	7 (8%)
11-14	13 (15%)
15-17	24 (29%)
18-21	39 (46%)
Gender
Female	34 (40%)
Male	50 (60%)
Race/ethnicity
Hispanic	30 (36%)
White	22 (26%)
Black	17 (20%)
Asian	2 (2%)
Pacific Islander	1 (1%)
Multiracial	1 (1%)
Not disclosed	11(13%)
Diagnosis
Crohn’s	55 (65%)
Ulcerative colitis	25 (30%)
Indeterminate	4 (5%)
Treatment
Anti-TNF	31 (37%)
Immunomodulator	30 (35%)
5-ASA	18 (21%)
Other	5 (6%)